NasdaqGS - Nasdaq Real Time Price USD
Neumora Therapeutics, Inc. (NMRA)
0.7518
+0.0409
+(5.75%)
As of 1:35:42 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-182,936
-182,936
-163,278
-114,896
-75,420
Investing Cash Flow
-70,557
-70,557
64,387
-168,013
-817
Financing Cash Flow
21,603
21,603
231,936
115,743
293,507
End Cash Position
143,361
143,361
375,251
242,206
409,372
Capital Expenditure
--
--
-117
-511
-817
Issuance of Capital Stock
13,694
13,694
233,375
112,216
292,139
Repurchase of Capital Stock
--
--
-491
--
--
Free Cash Flow
-182,936
-182,936
-163,395
-115,407
-76,237
12/31/2021 - 9/14/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALEC Alector, Inc.
1.1550
-0.43%
LYEL Lyell Immunopharma, Inc.
0.4592
-3.93%
CABA Cabaletta Bio, Inc.
1.2950
-3.36%
SEPN Septerna, Inc.
6.31
+2.77%
STRO Sutro Biopharma, Inc.
0.8719
-3.12%
SLRN Acelyrin, Inc.
2.1700
-3.56%
GOSS Gossamer Bio, Inc.
0.9665
+8.07%
RLYB Rallybio Corporation
0.2970
+0.47%
ACRV Acrivon Therapeutics, Inc.
1.9050
-4.75%
JSPR Jasper Therapeutics, Inc.
4.7450
+4.06%